Synergy of Host Defense Mechanisms in the Lung

肺部宿主防御机制的协同作用

基本信息

  • 批准号:
    8975431
  • 负责人:
  • 金额:
    $ 40.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-30 至 2019-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This application proposes to continue our studies on the intracellular lifestyle of the human pathogenic fungus Cryptococcus neoformans, which is a major pathogen of immunosuppressed individuals such as patients with AIDS, transplant recipients, and those on immunosuppressive therapy. C. neoformans is a facultative intracellular pathogen and is dependent on its ability to survive in macrophages for its pathogenic mechanisms. Perhaps the most dramatic effect observed with C. neoformans is the phenomenon of non-lytic exocytosis whereby fungal cells are released from macrophages without lysis or apparent damage to the host cells. Non-lytic phagocytosis involves contributions from both the fungus and host cells and it must be a remarkably well choreographed process whereby the phagosomal membrane fuses with the cell membrane to disgorge the phagosomal contents into the extracellular space without host cell lysis. The phenomenon of non-lytic exocytosis has now been documented in mammalian, insect, slime mold and protozoal cells indicating remarkable specificity for different hosts, a fact suggesting that it either exploits hihly conserved eukaryotic cellular mechanisms or includes redundant mechanisms. Preliminary studies indicate that two highly conserved eukaryotic cellular systems are involved in C. neoformans non-lytic exocytosis from macrophages: autophagy and annexins. Furthermore, the requirement for fungal viability in non-lytic exocytosis events implies active modification of the cryptococcal phagosome by the fungus. Consequently, this application proposes the following three specific aims: 1. To establish the relationship between macrophage damage and CN non-lytic exocytosis; 2. To establish the mechanism by which host annexins contribute to CN non-lytic exocytosis; 3. To identify the fungal components that facilitates non-lytic exocytosis.
 描述(由申请人提供):本申请提议继续我们对人类病原性真菌新型隐球菌的细胞内生活方式的研究,新型隐球菌是免疫抑制个体(例如艾滋病患者、移植受者和接受免疫抑制治疗的人)的主要病原体。C.新生菌是兼性细胞内病原体,其致病机制依赖于其在巨噬细胞中存活的能力。也许在C.新生菌是一种非溶解性胞吐现象,其中真菌细胞从巨噬细胞中释放而不溶解或对宿主细胞造成明显损伤。非溶解性吞噬作用涉及真菌和宿主细胞的贡献,并且它必须是一个非常精心设计的过程,其中吞噬体膜与细胞膜融合以将吞噬体内容物吐出到细胞外空间中而没有宿主细胞溶解。非溶解性胞吐现象现已在哺乳动物、昆虫、黏菌和原生动物细胞中被证实,表明对不同宿主具有显著的特异性,这一事实表明它利用高度保守的真核细胞机制或包括冗余机制。初步研究表明,C.来自巨噬细胞的新型非溶解性胞吐:自噬和膜联蛋白。此外,在非溶解性胞吐事件中对真菌活力的要求意味着真菌对隐球菌吞噬体的主动修饰。因此,本申请提出以下三个具体目的:1.建立巨噬细胞损伤与CN非溶解性胞吐的关系;建立宿主膜联蛋白参与CN非溶解性胞吐的机制; 3.鉴定促进非溶解性胞吐作用的真菌成分。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Arturo Casadevall其他文献

Arturo Casadevall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Arturo Casadevall', 18)}}的其他基金

The biology of Cryptococcus neoformans melanization
新型隐球菌黑化的生物学
  • 批准号:
    10660435
  • 财政年份:
    2023
  • 资助金额:
    $ 40.5万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10326944
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10410573
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
Exploiting antibody catalysis for treating Cryptococcosis
利用抗体催化治疗隐球菌病
  • 批准号:
    10609085
  • 财政年份:
    2021
  • 资助金额:
    $ 40.5万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision Supplement
用于预防和治疗隐球菌病的结合疫苗 - COVID-19 修订补充资料
  • 批准号:
    10265635
  • 财政年份:
    2020
  • 资助金额:
    $ 40.5万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10339408
  • 财政年份:
    2020
  • 资助金额:
    $ 40.5万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10582699
  • 财政年份:
    2020
  • 资助金额:
    $ 40.5万
  • 项目类别:
Conjugate vaccines for prevention and treatment of cryptococcosis
用于预防和治疗隐球菌病的结合疫苗
  • 批准号:
    10117191
  • 财政年份:
    2020
  • 资助金额:
    $ 40.5万
  • 项目类别:
Biological and Clinical Impact of Cryptococcal Extralcellular Vesicles
隐球菌细胞外囊泡的生物学和临床影响
  • 批准号:
    8958486
  • 财政年份:
    2014
  • 资助金额:
    $ 40.5万
  • 项目类别:
Development of new passive immunization strategies for anthrax
开发新的炭疽被动免疫策略
  • 批准号:
    8230240
  • 财政年份:
    2011
  • 资助金额:
    $ 40.5万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 40.5万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 40.5万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 40.5万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 40.5万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 40.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了